Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAVATAN BAK-free Switch Study in Glaucoma/Ocular Hypertension
NCT01493427Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Dec 2011
- Primary completion
- Feb 2013
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 4 trial of travoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Dec 2011; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01493427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493427.